KETKAR RAJENDRA D. 4
4 · Arcadia Biosciences, Inc. · Filed Sep 20, 2018
Insider Transaction Report
Form 4
KETKAR RAJENDRA D.
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-09-18+106,400→ 160,150 totalExercise: $4.63From: 2018-09-30Exp: 2028-09-18→ Common Stock (106,400 underlying)
Footnotes (1)
- [F1]The options will vest monthly in equal installments over a period of two years from the date of the grant, subject to the Participant's continued service.